Following its December 2025 IPO, Medline is facing increased expenses related to Sarbanes-Oxley compliance and other public company requirements. This creates a need for solutions in GRC, financial reporting, and investor relations.
Filing excerpt
We incurred additional costs associated with preparing to become a public company during fiscal years 2025 and 2024, and we expect to continue to incur additional costs associated with operating as a public company.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10kcomplianceBurdenGet every 10-K signal for Medline and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medline this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/82227766-34b0-45f7-bf7a-691459a122d0 returns this record as JSON. POST /v1/companies/enrich returns every signal for medline.com.
{
"signal_id": "82227766-34b0-45f7-bf7a-691459a122d0",
"signal_type": "sec-10k",
"signal_subtype": "complianceBurden",
"detected_at": "2026-03-03T05:49:05.617+00:00",
"company": {
"name": "Medline",
"domain": "medline.com"
},
"data": {
"detail": "Following its December 2025 IPO, Medline is facing increased expenses related to Sarbanes-Oxley compliance and other public company requirements. This creates a need for solutions in GRC, financial reporting, and investor relations.",
"metrics": {
"timeframe": "multi_year"
},
"summary": "Incurring new compliance costs post-IPO under Sarbanes-Oxley",
"excerpts": "We incurred additional costs associated with preparing to become a public company during fiscal years 2025 and 2024, and we expect to continue to incur additional costs associated with operating as a public company.",
"relevance": 0.7,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/mdln-20251231.htm",
"filing_date": "2026-02-25",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "GRC tools needed",
"signal_category": "risk"
}
}
curl https://signals.autobound.ai/v1/signals/82227766-34b0-45f7-bf7a-691459a122d0 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"medline.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.